Read + Share
Nyffenegger N, Zennadi R, Kalleda N, Flace A, et al. The oral ferroportin inhibitor vamifeport improves hemodynamics in a mouse model
of sickle cell disease. Blood 2022;140:769-781.
PMID: 35714304
|
 |
|
Nyffenegger N, Zennadi R, Kalleda N, Flace A, et al. The oral ferroportin inhibitor vamifeport improves hemodynamics in a mouse model
of sickle cell disease. Blood 2022;140:769-781.
PMID: 35714304
|
|
|
|